Novel persistent activation of muscarinic M1 receptors by xanomeline
- 1 September 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 334 (1) , R3-R4
- https://doi.org/10.1016/s0014-2999(97)01162-x
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer DiseaseArchives of Neurology, 1997
- Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.Proceedings of the National Academy of Sciences, 1989
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982